To Be Discontinued Solution Psychiatry
Sodium Oxybate Solution · 256 days since initial FDA posting
Brand: SODIUM OXYBATE
FDA lists Sodium Oxybate Solution as To Be Discontinued (Amneal Pharmaceuticals).
No availability text on this FDA row.
Sodium Oxybate Solution: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sodium Oxybate Solution
- Manufacturer
- Amneal Pharmaceuticals
- Dosage Form
- Solution
- Presentation
- Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1)
- Package NDC
- 69238-2391-1
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Dec 29, 2025
- Last Updated
- Dec 29, 2025
- Therapeutic Category
- Psychiatry
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.